World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
34
Citations
4797
World Ranking
9333
National Ranking
174

Eva Kumlien publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Eva Kumlien sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 101 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Eva Kumlien D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Eva Kumlien sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 34 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Eva Kumlien is a researcher affiliated with Uppsala University in Sweden, specializing in the field of medicine with a primary focus on neurology. Their work encompasses various subfields including neurology, infectious diseases, psychiatry and mental health, critical care and intensive care medicine, as well as pediatrics, perinatology, and child health.

Their research topics cover several areas related to neurological and infectious disease conditions, notably:

  • Long-Term Effects of COVID-19
  • Epilepsy research and treatment
  • COVID-19 Clinical Research Studies
  • Intensive Care Unit Cognitive Disorders
  • Pharmacological Effects and Toxicity Studies
  • Autoimmune Neurological Disorders and Treatments
  • Infectious Encephalopathies and Encephalitis

Eva Kumlien has contributed to multiple scientific articles published in reputable journals. Some of the recent papers include:

  • Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid (2020, Neurology)
  • Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity (2020, European Journal of Neurology)
  • Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study (2021, Clinical Neurophysiology)
  • Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Drug-Resistant Epilepsy in the MORE Multicenter Patient Registry (2023, Neurology)
  • Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke Epilepsy (2021, JAMA Neurology)

They frequently publish in journals such as:

  • Neurology
  • European Journal of Neurology
  • Clinical Neurophysiology
  • Brain Behavior and Immunity
  • JAMA Neurology

Collaborations form an important part of their research activity. Frequent coauthors include:

  • Elham Rostami
  • Johan Virhammar
  • David Fällmar
  • Janet L. Cunningham
  • Robert Frithiof

Best Publications

  • Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry

    Torbjörn Tomson;Torbjörn Tomson;Dina Battino;Erminio Bonizzoni;John Craig

  • Seizure control and treatment in pregnancy: Observations from the EURAP epilepsy pregnancy registry

    Torbjörn Tomson;D. Battino;E. Bonizzoni;J. Craig

  • Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.

    Johan Virhammar;Eva Kumlien;David Fällmar;Robert Frithiof

  • Empirical evidence of underutilization of referrals for epilepsy surgery evaluation.

    P. de Flon;E. Kumlien;Christina Reuterwall;P. Mattsson

  • Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation

    E. E. Kors;A. Melberg;K. R.J. Vanmolkot;E. Kumlien

  • Long-term outcomes of epilepsy surgery in Sweden A national prospective and longitudinal study

    Anna Edelvik;Bertil Rydenhag;Ingrid Olsson;Roland Flink

  • Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.

    Eva Kumlien;Per Olov Lundberg

  • Health‐Related Quality of Life After Epilepsy Surgery: A Swedish Multicenter Study

    Kristina Malmgren;Marianne Sullivan;Gerd Ekstedt;Gunvor Kullberg

  • Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.

    Johan Virhammar;Anja Nääs;David Fällmar;Janet L Cunningham

  • Attitudes towards epilepsy surgery: A nationwide survey among Swedish neurologists

    Eva Kumlien;Peter Mattsson

  • Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study.

    Robert Frithiof;Elham Rostami;Eva Kumlien;Johan Virhammar

  • NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy.

    Eva Kumlien;Per Hartvig;Sven Valind;Ivar Øye

  • Preoperative heart rate variability in relation to surgery outcome in refractory epilepsy

    H Persson;Eva Kumlien;M Ericson;Torbjörn Tomson

  • Cerebral glutamine and glutamate levels in relation to compromised energy metabolism : a microdialysis study in subarachnoid hemorrhage patients

    Carolina Samuelsson;Lars Hillered;Maria Zetterling;Per Enblad

  • Circadian variation in heart-rate variability in localization-related epilepsy

    Håkan Persson;Eva Kumlien;Mats Ericson;Torbjörn Tomson

  • Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Drug-Resistant Epilepsy in the MORE Multicenter Patient Registry

    Unknown

  • The current state of epilepsy guidelines: A systematic review.

    Khara M. Sauro;Samuel Wiebe;Colin Dunkley;Jozsef Janszky

  • PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy.

    Eva Kumlien;A Nilsson;G Hagberg;B Langstrom

  • The diagnosis and treatment of limbic encephalitis

    F. Asztely;Eva Kumlien

  • Preliminary results of the global audit of treatment of refractory status epilepticus

    M. Ferlisi;S. Hocker;M. Grade;E. Trinka

  • Decreased cortical levels of astrocytic glutamate transport protein GLT-1 in a rat model of posttraumatic epilepsy.

    Carolina Samuelsson;Eva Kumlien;Roland Flink;Dan Lindholm

  • Treatment outcome in patients with mesial temporal sclerosis.

    Eva Kumlien;Robert C Doss;John R Gates

Frequent Co-Authors

Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Mats Fredrikson
Mats Fredrikson Uppsala University
Kristina Malmgren
Kristina Malmgren University of Gothenburg
Torbjörn Tomson
Torbjörn Tomson Karolinska Institute
Bengt Långström
Bengt Långström Uppsala University
Elna-Marie Larsson
Elna-Marie Larsson Uppsala University
Reetta Kälviäinen
Reetta Kälviäinen University of Eastern Finland
Sanjeev V Thomas
Sanjeev V Thomas Institute for Communicative and Cognitive Neurosciences
Kaj Blennow
Kaj Blennow University of Gothenburg
Bertil Rydenhag
Bertil Rydenhag University of Gothenburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are drawn to Neuroscience, a number of related online degree options can support your passion and expand your career options. Many students interested in the science of the brain also pursue fields like counseling, psychology, or therapy—areas that are growing quickly and often offer flexible study options.

Choosing a program can be challenging, but today’s online landscape provides access to cacrep-accredited programs online, allowing you to study counseling at high academic standards from anywhere. Those seeking value may also explore the most affordable online counseling degrees now being offered by many respected institutions.

Another opportunity is in marriage and family therapy, a field where an online degree can help meet licensure requirements. See your options for a marriage and family therapy degree online to compare costs and curricula.

Finally, if you are considering a graduate degree, it’s important to understand how much does masters in psychology cost and how it can align with diverse neuroscience-related career paths from research to clinical practice.

Best Scientists Citing Eva Kumlien

Trending Scientists